News

DENTOXOL® ENTERS GES PROGRAMME
Ingalfarma announces that its product Dentoxol® has been incorporated into

PUBLICATION OF ESDOM STUDY
Ingalfarma announces the recent publication of its Multicenter, Phase 2,

DIARIO FINANCIERO HIGHLIGHTS THE USE OF DENTOXOL® IN POST-VENTILATED PATIENTS
Ingalfarma performs product tests on COVID-19 patients connected to mechanical

GRANT OF CORFO FUNDS FOR INTERNATIONALIZATION
To support its 2020-2021 internationalization plan, Ingalfarma has been awarded
contact
Si quieres contactarnos, por favor escríbenos a:
contacto@ingalfarma.com o bien llámanos al teléfono +56 2 2902 3022
contacto@ingalfarma.com o bien llámanos al teléfono +56 2 2902 3022